Cargando…

Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter

Detalles Bibliográficos
Autores principales:	Violet, Pierre-Christian, Levine, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405158/ https://www.ncbi.nlm.nih.gov/pubmed/28292579 http://dx.doi.org/10.1016/j.ebiom.2017.03.014

Ejemplares similares

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
por: Xia, Jiliang, et al.
Publicado: (2017)

Pharmacological dose ascorbic acid administration in relapsed refractory multiple myeloma patients
por: Bolaman, Ali Zahit, et al.
Publicado: (2021)

Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial
por: Coppock, Dagan, et al.
Publicado: (2022)

High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
por: Polireddy, Kishore, et al.
Publicado: (2017)

Correction: Coppock et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. Life 2022, 12, 453
por: Coppock, Dagan, et al.
Publicado: (2022)

Is aggressive treatment of smoldering myeloma the path to curing myeloma?
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Epigenetic effects of pharmacologic ascorbate
por: Steers, Garett J., et al.
Publicado: (2021)

Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer
por: Steers, Garett J., et al.
Publicado: (2022)

Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance
por: Bloomfield, Roxanna, et al.
Publicado: (2006)

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015)

Towards characterized convalescent plasma for COVID-19: The dose matters
por: Verkerke, Hans P., et al.
Publicado: (2020)

Ascorbic acid co-administration with artemisinin based combination therapies in falciparum malaria
por: Marwaha, Neelam
Publicado: (2016)

The role of mitochondria in pharmacological ascorbate-induced toxicity
por: Du, Juan, et al.
Publicado: (2022)

Relevant Membrane Transport Proteins as Possible Gatekeepers for Effective Pharmacological Ascorbate Treatment in Cancer
por: Leischner, Christian, et al.
Publicado: (2023)

Oral Sulfate Solution is as Effective as 2 L Polyethylene Glycol Plus Ascorbic Acid
por: Shin, Sung Hyun, et al.
Publicado: (2020)

Approach to Optimize Pharmacological Treatment in Children
por: Olguín, Hugo Juárez
Publicado: (2019)

High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
por: Luchtel, Rebecca A., et al.
Publicado: (2020)

In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs
por: Musser, Margaret L., et al.
Publicado: (2019)

Progress in multiple myeloma
por: Munker, Reinhold, et al.
Publicado: (2019)

Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq
por: Darweesh, Omeed, et al.
Publicado: (2021)

Panobinostat and Multiple Myeloma in 2018
por: Yee, Andrew J., et al.
Publicado: (2018)

The dual effect of pharmacological ascorbate on radiation: The best of both worlds
por: Cullen, Joseph J.
Publicado: (2018)

Hepatomas are exquisitely sensitive to pharmacologic ascorbate (P-AscH(-))
por: Zhang, Xuan, et al.
Publicado: (2019)

Treatment of Irradiated Mice with High-Dose Ascorbic Acid Reduced Lethality
por: Sato, Tomohito, et al.
Publicado: (2015)

The Matter of Non-Avian Reptile Sentience, and Why It “Matters” to Them: A Conceptual, Ethical and Scientific Review
por: Learmonth, Mark James
Publicado: (2020)

Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
por: Schuh, Michael J., et al.
Publicado: (2022)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
por: Grasso, Carole, et al.
Publicado: (2014)

Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report
por: Wu, Shuxie, et al.
Publicado: (2018)

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo
por: Niessner, Heike, et al.
Publicado: (2022)

Clinical Interpretation of Efficacy Outcomes in Pharmacological Studies on Triple Fixed-Dose Combination Therapy for Uncontrolled Asthma: Assessment of IRIDIUM and ARGON Studies
por: Rogliani, Paola, et al.
Publicado: (2022)

Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
por: Tenenbaum, Alexander, et al.
Publicado: (2018)

Reimagining diversity in multiple myeloma clinical trials
por: Habr, Dany, et al.
Publicado: (2022)

CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)

Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate
por: Du, Juan, et al.
Publicado: (2021)

Therapeutic Approach of KRAS Mutant Tumours by the Combination of Pharmacologic Ascorbate and Chloroquine
por: Kapuy, Orsolya, et al.
Publicado: (2021)

Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy
por: Zaher, Amira, et al.
Publicado: (2022)

High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
por: Burkard, Markus, et al.
Publicado: (2023)

Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)
por: Renner, Olga, et al.
Publicado: (2021)

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
por: Nauman, Gina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4l5t7vtg9u7qpav1akuji8vag2